interventions may have a greater impact on the population's health than any improvement in specific medical treatments. 6, 7 As a result, numerous studies have examined predictors of compliance with antipsychotic medication both in chronic schizophrenia 8, 9 and in recent-onset psychosis. 10, 11 Given this background, it is surprising that, with some recent exceptions, 12, 13 little research has focused on those factors affecting compliance with CBT in patients with schizophrenia. To our knowledge, no previous study has examined the predictors of adherence to CBT in FEP patients.
Our study sought to investigate predictors of adherence to CBT in an RCT (the EPISODE II trial) designed to evaluate the effectiveness of a cognitive-behavioural intervention for relapse prevention in clinically remitted FEP patients when compared against treatment as usual. In a recent publication, we have reported the effectiveness of this intervention in reducing relapse rates in FEP patients over a 7-month follow-up period. 14 Our study reports on those factors associated with adherence to CBT.
Method
The EPISODE II trial comprised a prospective, single-blind, randomized controlled effectiveness trial that compared a combined individual CBT and family intervention for relapse prevention with treatment as usual within 2 high-quality, youth-oriented, specialist FEP programs. The EPISODE II trial was designed to test numerous hypotheses regarding both clinical outcomes and psychological processes linked with psychosis and included a total of 6 assessment time points spanning a 2.5-year follow-up period. A detailed description of the EPISODE II rationale, sample and methodology has been provided elsewhere, 14, 15 and it will be only briefly described in this paper.
Participants, Recruitment, and Assignment
Patients from the EPPIC in Melbourne and Barwon Health were recruited between November 2003 and May 2005. Inclusion criteria for entry to the trial were as follows: aged 15 to 25 years inclusive; meeting the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for a first episode of a psychotic disorder; less than 6 months of prior treatment with antipsychotic medication; and remission of positive psychotic symptoms, defined as 4 weeks or more of scores of 3 (mild) or below on the BPRS items hallucinations, unusual thought disorder, conceptual disorganization, and suspiciousness. 17 Eligible patients and their families were invited to participate by the project research assistants as soon as possible after they reached remission on positive psychotic symptoms. Baseline measures were administered by research assistants who were blind to treatment allocation before randomization to treatment as usual or to the cognitive-behavioral intervention. Random allocation was managed by the study statistician using computer-generated random numbers. The trial coordinator, who was informed of the outcome of randomization through email and telephone, informed the treating team of the outcome. The statistician was not involved in any way with either the assessments or the treatments.
All potential participants who met inclusion criteria were given the opportunity to participate. All participants provided informed consent and were assessed as competent to do so. Patients provided additional optional consent for participation of their family members. For participants aged 18 years or younger, consent was also obtained from a parent or guardian. Our study was approved by the Northwestern Mental Health and the Barwon Health Research and Ethics Committees.
Treatment Groups
The individual intervention was manual-based and was comprised of 5 phases of therapy underpinned by a CBT framework, and informed by previous psychotherapy trials conducted at EPPIC and by the collaborative therapy framework developed at the Mental Health Research Institute, Melbourne, Australia. 1, 18 The aim of the first phase of the individual therapy was to engage the patient and assess their extent of recovery and risk for relapse. In the second phase, the formulation and agenda for therapy were agreed on with the patient and summarized in a letter, which was read out to the patient-a technique informed by cognitive analytic therapy. 19 The third phase focused on increasing awareness for the risk of setbacks and how to minimize them, and in the fourth the potential early warning signs of relapse were identified and a relapse plan formulated. 19 The fifth phase included CBT modules that addressed issues of nonadherence to treatment, substance abuse, coping with stress, and comorbid anxiety and depression. The final phase included a review and termination, and a booster session. CBT was provided within a 7-month therapy window, about fortnightly to match with the recommended frequency of sessions in treatment as usual. 20 The cognitive-behavioral intervention was undertaken by 2 clinical psychologists who had numerous years of clinical experience within EPPIC outpatient services. Research therapists received weekly supervision by experienced cognitivebehavioural therapists to ensure treatment quality. In addition, individual therapy sessions were audiotaped and treatment fidelity procedures were undertaken to ensure treatment integrity. Specifically, a representative sample of sessions (n = 46) stratified by therapy phase was rated on a specifically designed fidelity measure (RPT-FS), which included subscales for each phase of therapy. 21 The RPT-FS was designed to assess both treatment adherence and therapist competence as defined by the intervention manual. Therapy sessions were randomly ordered and coded by the study statistician and rated by 2 clinical psychologists who scored all tapes according to the RPT-FS subscales and made blind judgments about which phase of therapy was being carried out. Sessions were correctly allocated in 43 of the 46 audiotapes rated. 21 Copies of the RPT-FS and rating manual are available on request.
The family intervention was informed by cognitivebehavioural family therapy for schizophrenia 22, 23 and family interventions for FEP. 24 The family therapy was also manualized, provided by a trained family therapist, and comprised the following phases: assessment and engagement, assessment of family communication, burden and coping, psychoeducation regarding relapse risk, and a review of early warning signs and documentation of a relapse prevention plan. Intensive communication skills training and problemsolving were carried out where indicated. 14 Patients randomized to treatment as usual continued with their routine treatment through the EPPIC program or Barwon Health, which included home-based treatment and a range of psychosocial interventions. 14 Treatment as usual case managers were provided with specific documented guidelines regarding the frequency of follow-up and an outline of the treatments that should be covered in relation to phases of recovery. 20 At entry into the service, all families were routinely offered access to a brief family psychoeducation group, and EPPIC families had access to a family peer support service. 14
Assessment Procedures
Adherence to CBT The cognitive-behavioural intervention was designed to be implemented in a flexible manner. The number of sessions to be undertaken was based on a collaborative formulation agenda as well as the ongoing assessment of the needs of each patient. Therefore, adherence with CBT was defined as completion of the intervention as clinically indicated by the treating clinical psychologist. Additionally, patients who completed about 80% of the planned intervention were considered adherent. In contrast, patients who did not initiate the intervention, terminated against the therapist's advice, or did not complete at least 80% of the treatment protocol, were considered nonadherent.
Predictor Measures
We considered potential baseline predictors from 6 different domains: sociodemographic characteristics, DUP and premorbid measures, insight, symptoms measures, psychosocial functioning, and family measures.
Selection of potential predictors was informed by previous research on engagement with services for psychosis, 25 compliance with antipsychotic medication, 26 and adherence with psychotherapy. 27 DUP was included because recent theoretical models posit that treatment delay may limit the potential clinical benefits of psychosocial interventions for FEP patients. 28, 29 Premorbid measures were considered as potential confounders of the relation between DUP and adherence with CBT. 30, 31 Family measures were included given the relation between expressed emotion, family burden, and levels of anxiety and depression in FEP patients. 32 Sociodemographic characteristics investigated included sex, age, employment status (employed, not employed, studying), living arrangements (percentage living with family), years of schooling, and marital status. DUP was defined as the time from onset of psychosis to initiation of adequate treatment. Onset of psychosis was equated to the first manifestation of continuous psychotic symptoms corresponding to a score of 5 or more on any 1 of 3 BPRS items (unusual thought content, hallucinations, or conceptual disorganization). Adequate treatment was defined as the start of structured treatment with either antipsychotic medication or intensive psychosocial intervention (provided by EPPIC outreach teams), or the start of hospitalization in a specialized psychiatric ward. DUP was assessed through a consensus process, involving 3 clinical psychologists and a research assistant, using all available sources including medical records and semistructured clinical interviews with patients and relatives.
Premorbid functioning was assessed through the PAS. The PAS is designed to measure premorbid functioning from a developmental perspective, conceptualizing good premorbid adjustment as the achievement of age-appropriate development and social milestones. 33 Insight was assessed by using the SUMD. 34 The SUMD evaluates several dimensions of insight including awareness of mental disorder, awareness, and attribution of the achieved effects of medication, and awareness and attribution of psychotic symptoms. This scale also distinguishes between current (which refers to existing symptoms) and retrospective insight. The SUMD was designed to enable any subscale to be used independently depending on the goals of the investigation. Given that our study comprised remitted FEP patients, and there was a substantial number of missing values for the subscales referring to current symptoms, we only included retrospective judgments of psychotic symptoms. Higher scores on this scale indicate less insight.
Symptom measures included the Montgomery-Åsberg Depression Rating Scale, 35 a measure of the severity of depressive symptoms, the BPRS, 36 which provides severity ratings across a broad range of psychotic and nonpsychotic symptoms, and the the Scale for the Assessment of Negative Symptoms, 37 a scale specifically developed to measure negative symptoms.
Psychosocial functioning measures included the Social and Occupational Functional Outcome Scale, 38 developed as a measure of global social and occupational functioning measure that does not include the severity of symptoms.
Family-expressed emotion was assessed using the Family Questionnaire. 39 Family well-being was measured with the General Health Questionnaire, 40 and the Experience of Caregiving Inventory. 41 Finally, antipsychotic treatment at baseline was included as a potential predictive variable for compliance with CBT. Antipsychotic treatment was categorized as a dichotomous variable (taking antipsychotic medication at baseline, compared with not taking antipsychotic medication).
Statistical Analysis
Only data on patients included in the experimental arm of the RCT were used in proceeding analyses. Data screening was conducted to determine the presence of outliers, nonnormality, heterogeneity of variance, and heteroscedasticity. When data deviated from the normal Gaussian curve, logarithmic transformations were conducted. Descriptive statistics are presented for untransformed data.
We conducted 2 sets of logistic regression analyses to identify significant independent predictors of compliance with CBT. Firstly, we performed a series of univariate logistic regression models including one potential predictor at a time to evaluate their association with therapy compliance. The relevance of each variable was assessed following the Hosmer-Lemeshow method. 42 This method recommends excluding variables with little predictive power (P > 0.30) from subsequent analysis to obtain clinically relevant and stable models. Subsequently, we fitted all possible multilevel logistic regression models for multiple predictor variables and ranked the models by Mallows' Cp statistic (a measure of goodness of fit of the model). The performance of the models was further assessed by the area under the receiver operating characteristic curve 43 and the Nagelkerke's R 2 statistic (a measure of the proportion of explained variation in the logistic model). 44 Finally, the relevant variables resulting from the analysis were force-entered into successive models before the introduction of potential confounding variables. Therefore the association between significant predictors and compliance with therapy were corrected for the influences of the remaining variables. According to Freeman's classic approach, logistic regression analysis requires 10 subjects per predictor variable plus one. 45 Given our study was comprised of 41 participants, logistic regression models including 4 predictor variables were considered statistically powerful. All models were validated graphically and analytically. Statistical analyses were conducted using the SPSS, Version 15.0 (SPSS Inc, Chicago, IL).
Results

Participant Characteristics
Our study sample consisted of 81 participants, of whom 41 were allocated to CBT and 40 to treatment as usual. Reasons for exclusions have been reported elsewhere. 15 Patients who consented and did not consent did not differ significantly on the following variables: sex, age, marital status, highest level of education, weeks in the service, levels of unemployment, and living arrangements (that is, percentage living with family). Further, there were no significant differences between the CBT and the treatment as usual groups about any of the demographics or clinical variables. For the purpose of our study, only baseline characteristics of the CBT group are presented in Table 1 .
Sixty-six of the participants (82%) consented to their family being involved, of whom 32 were allocated to the intervention group. Baseline characteristics of those families are depicted in Table 2 .
Predictors of Adherence With CBT
Participants randomized to CBT completed a mean of 8.51 (SD 4.87) sessions. Twenty-eight participants (68.3%) completed the CBT intervention, compared with 13 (31.7%) who prematurely discontinued or did not attend. Therapy completers received a mean of 11.54 sessions (SD 1.71, range 8 to 14).
We first examined all potential predictors of therapy compliance including sociodemographic factors, premorbid, symptomatic and functional variables, antipsychotic treatment (that is, yes or no), and insight as well as family measures in a series of univariate logistic regression models. Those variables with little predictive power (P > 0.30) were excluded from additional analysis. As a result of this process, the following variables were retained for the multivariate analysis: BPRS (P = 0.19), DUP (P = 0.04), social and academic premorbid functioning (P = 0.27), and 3 SUMD subscales: awareness of psychotic symptoms (P = 0.03), mistaken attribution of psychotic symptoms (P = 0.15); and past awareness of mental disorder (P = 0.28). Subsequently, all possible multilevel logistic regression models for these predictor variables and first-order interactions were fitted and their performance assessed by Mallows' Cp statistic, the area under the receiver operating characteristic curve, and the Nagelkerke R 2 statistic.
Multivariate models identified 2 factors which were independent predictors of compliance with therapy: DUP (OR 0.21, 95% CI 0.06 to 0.78; P = 0.02) and the level of insight (awareness of psychosis symptoms) (OR 0.44, 95% CI 0.22 to 0.89; P = 0.02) ( Table 3) . Participants with longer DUP as well as a poorer level of insight were less likely to adhere to the CBT intervention. The model that included both variables had good powers of discrimination (area under the curve = 0.90) and explained a significant proportion of the variation in adherence with therapy (Nagelkerke R 2 = 0.45) (P < 0.001). Further, there was no evidence of correlation between both variables (r 2 = 0.002; P = 0.99).
Additional analyses were performed to evaluate the predictive properties of the model after controlling for potential confounding factors. First, DUP and insight were force-entered into a logistic regression model before the introduction of potential confounding variables including sex, age, and BPRS. In the adjusted model, both the DUP (OR 0.22, 95% CI 0.06 to 0.85; P = 0.02) and the insight (OR 0.42, 95% CI 0.20 to 0.90; P = 0.02) variables remained unchanged and significant ( Table 3 ). The adjusted model performance (Nagelkerke R 2 = 0.46) was similar to that of the best model obtained in the multivariate analysis (Nagelkerke R 2 = .45), which indicated little additional predictive value for the control variables. Second, given the possibility that premorbid adjustment may be a potential confounder for the association between DUP and outcomes, 31 we controlled for the effect of social and academic premorbid functioning. Again, the corrected odds ratios were similar to those reported above (OR 0.14, P = 0.02 and OR 0.49, P = 0.04 for DUP and insight, respectively).
Discussion
Our study is the first to the best of our knowledge, to examine predictors of compliance with a cognitive-behavioural intervention in a cohort of young patients with recent-onset psychosis. Longer DUP and lower level of insight emerged as the strongest predictors of poorer adherence with CBT, the association remaining strong and significant even after controlling for potential confounders. The predictive model that included both variables accounted for a substantial proportion of the variance of compliance with CBT and exhibited good predictive performance.
DUP and Adherence With CBT Early Intervention in Psychosis
Most FEP studies show an association between long DUP and poorer short-term outcome, 46 although some have questioned this finding. 47 While the mechanism of this association remains to be fully understood, 48 experiencing psychotic symptoms for months or even years is likely to adversely affect social, occupational, and interpersonal functioning. There is also recent evidence to show that reducing the DUP is associated with better clinical status at both baseline and short-term follow-up. 49 These findings provide support for early identification and intervention for psychosis. 28 According to this therapeutic approach, the early years beyond the first episode are crucial in setting the parameters for longer-term recovery and outcome. 50, 51 Accordingly, treatment delay would reduce the therapeutic potential of interventions provided early in the course of the illness.
Results from our study lend support to this notion by showing that early commencement of treatment enhances compliance with psychological intervention approaches irrespective of potential confounders. This finding is in contrast with previous research that found no evidence of an association between DUP and adherence to antipsychotic medication. 52 But, how could a short DUP favour adherence in CBT and not in antipsychotics medications?
The relation between DUP and adherence to CBT may be explained by psychosocial and neuropsychological factors. First, longer DUP may severely disrupt a young person's developmental trajectory, affecting their social functioning and interfering with their ability to engage in structured psychological interventions. Second, extended DUP has been associated with cognitive deficits including poor working memory, executive functioning impairments, and suboptimal problem-solving, 53, 54 although several studies have questioned this association. 55, 56 Cognitive deficits may therefore interfere with a young person's ability to engage with existing forms of CBT as cognitive therapies require young patients to use memory and problem-solving functions. Alternatively, given previous conflicting findings regarding the association between DUP and cognitive deficits in FEP, cognitive functioning may only affect adherence to CBT in some subgroups of patients. Future studies examining the relation between decline in social and cognitive functioning and adherence to CBT would represent a useful extension to our study. Interestingly, we did not find an association between negative symptoms and compliance with therapy in our sample. This indicates that treatment delay may not affect adherence to CBT through an increase in negative symptoms. Schmitz et al 57 recently proposed that the relation between DUP and negative symptoms may differ among subgroups of FEP patients. Namely, while for some patients there may be a positive relation between DUP and negative symptoms, for others there may be a negative association or none at all. 57 Taken together, these findings suggest that negative symptoms may only affect adherence to CBT in subgroups of FEP patients. Further investigations of the relation between DUP, negative symptoms, and compliance with therapy are therefore warranted.
Insight and Adherence to CBT
Results from our study also indicated that poorer insight was related to worse compliance to CBT. Again, while there is compelling evidence that lack of insight is a strong predictor of medication nonadherence in patients with schizophrenia, 58 little research has focused on the impact of insight on compliance with CBT in early-onset psychosis. Congruent with our findings, a recent study has shown a reduction in insight at follow-up for those participants with chronic schizophrenia who ceased CBT. 13 According to Tait et al, 25 lower insight reflects a psychological process of minimization of symptoms and the impact of psychosis. McGlashan et al 59 referred to this coping strategy as sealing over, implying that patients who use this recovery style are less likely to attempt to understand their symptoms or to place their psychotic experiences in perspective with their lives. Given the encouragement that CBT provides to people to integrate and understand their symptoms and illness, it may be plausible that patients with poorer current insight experienced the therapy as somewhat more threatening and (or) incongruent with their perceived needs which may precipitate discontinuation of therapy (Figure 1 ). 
Figure 1 Association between predictor variables, postulated underlying mechanisms, and adherence to CBT
Limitations
Our study has some limitations. First, the results of our study may not apply to the general population of remitted FEP patients because participants consented to take part in a therapy-based RCT. Second, we did not assess other factors that might be related to adherence to CBT. As mentioned earlier, the inclusion of cognitive deficits, decline in social functioning, and recovery style would provide a useful extension of the present findings. In addition, other variables such as therapeutic alliance, personality characteristics, or stigma could influence adherence with therapy and should be addressed in further studies. Third, as family therapy was concurrently provided it was not possible to determine the effect of receiving family interventions on adherence to individual CBT. Finally, given the relatively small sample size (n = 41), this study had limited power to detect small effects. Larger, multisite studies may be able to identify additional variables associated with therapy compliance.
Conclusion
Enhancing adherence to effective interventions is critical in the treatment of early-onset psychosis. Findings from our study suggest that longer DUP and lower level of insight predict poorer adherence to an effective CBT intervention in FEP patients. Future research should consider the role of therapeutic alliance, personality, stigma, and the sealing over recovery style to better understand and improve adherence to CBT in young people with psychosis. In the meantime, this novel finding emphasizes the relevance of both efficient early detection strategies in the community and therapeutic strategies to promote insight early in the course of the illness. Prompt delivery of effective treatments in FEP patients as well as early interventions to promote insight are likely to improve patients' adherence to CBTs. As a result, clinicians should consider patients with long DUP and poor insight particularly vulnerable to discontinue therapy prematurely and employ early strategies to foster therapeutic compliance.
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